WallStreetZenWallStreetZen

NASDAQ: AXDX
Accelerate Diagnostics Inc Stock

$1.26-0.02 (-1.56%)
Updated Jun 24, 2024
AXDX Price
$1.26
Fair Value Price
N/A
Market Cap
$27.78M
52 Week Low
$0.73
52 Week High
$8.72
P/E
-0.28x
P/B
-1.08x
P/S
1.56x
PEG
N/A
Dividend Yield
N/A
Revenue
$12.17M
Earnings
-$59.05M
Gross Margin
18.6%
Operating Margin
-406.31%
Profit Margin
-485.3%
Debt to Equity
-2.19
Operating Cash Flow
-$35M
Beta
1.15
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AXDX Overview

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AXDX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AXDX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AXDX is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
AXDX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more AXDX due diligence checks available for Premium users.

Be the first to know about important AXDX news, forecast changes, insider trades & much more!

AXDX News

Valuation

AXDX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.28x
Industry
30.8x
Market
30.03x

AXDX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-1.08x
Industry
3.87x

AXDX's financial health

Profit margin

Revenue
$2.9M
Net Income
-$14.2M
Profit Margin
-487.2%
AXDX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
AXDX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$30.7M
Liabilities
$56.5M
Debt to equity
-2.19
AXDX's short-term assets ($24.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AXDX's long-term liabilities ($40.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AXDX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AXDX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.5M
Investing
-$513.0k
Financing
$11.4M
AXDX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AXDX vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
AXDX$27.78M-1.56%-0.28x-1.08x
CUTR$27.70M-10.39%-0.17x-0.14x
MDAI$29.20M+5.03%-1.43x-14.40x
MOVE$29.87M-16.48%-0.55x-20.21x
NMTC$24.24M+7.70%-1.52x6.29x

Accelerate Diagnostics Stock FAQ

What is Accelerate Diagnostics's quote symbol?

(NASDAQ: AXDX) Accelerate Diagnostics trades on the NASDAQ under the ticker symbol AXDX. Accelerate Diagnostics stock quotes can also be displayed as NASDAQ: AXDX.

If you're new to stock investing, here's how to buy Accelerate Diagnostics stock.

What is the 52 week high and low for Accelerate Diagnostics (NASDAQ: AXDX)?

(NASDAQ: AXDX) Accelerate Diagnostics's 52-week high was $8.72, and its 52-week low was $0.73. It is currently -85.55% from its 52-week high and 72.6% from its 52-week low.

How much is Accelerate Diagnostics stock worth today?

(NASDAQ: AXDX) Accelerate Diagnostics currently has 22,050,515 outstanding shares. With Accelerate Diagnostics stock trading at $1.26 per share, the total value of Accelerate Diagnostics stock (market capitalization) is $27.78M.

Accelerate Diagnostics stock was originally listed at a price of $270.00 in Dec 31, 1997. If you had invested in Accelerate Diagnostics stock at $270.00, your return over the last 26 years would have been -99.53%, for an annualized return of -18.65% (not including any dividends or dividend reinvestments).

How much is Accelerate Diagnostics's stock price per share?

(NASDAQ: AXDX) Accelerate Diagnostics stock price per share is $1.26 today (as of Jun 24, 2024).

What is Accelerate Diagnostics's Market Cap?

(NASDAQ: AXDX) Accelerate Diagnostics's market cap is $27.78M, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Accelerate Diagnostics's market cap is calculated by multiplying AXDX's current stock price of $1.26 by AXDX's total outstanding shares of 22,050,515.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.